Babak Alaei-Mahabadi
AstraZeneca (Sweden)(SE)University of Gothenburg(SE)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, RNA Research and Splicing, Virus-based gene therapy research, Genetics, Aging, and Longevity in Model Organisms, CRISPR and Genetic Engineering
Most-Cited Works
- → The landscape of viral expression and host gene fusion and adaptation in human cancer(2013)311 cited
- → Simultaneous DNA and RNA Mapping of Somatic Mitochondrial Mutations across Diverse Human Cancers(2015)127 cited
- → Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery(2020)98 cited
- → Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancers(2016)56 cited
- → Temporal separation of replication and transcription during S-phase progression(2014)47 cited
- → Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown Primary(2018)15 cited
- → Limited evidence for evolutionarily conserved targeting of long non-coding RNAs by microRNAs(2013)11 cited
- → ObLiGaRe doxycycline Inducible (ODIn) Cas9 system driving pre-clinical drug discovery, from design to cancer treatment(2020)3 cited
- Comprehensive analysis of structural genomic alterations in cancer(2018)
- → Systematic investigation of promoter substitutions resulting from somatic intrachromosomal structural alterations in diverse human cancers(2020)